Oxford Immunotec Usa, Inc.
- UEI
- XVW6MZUM8NH3
- CAGE
- 94ZE6
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- oxfordimmunotec.com
- Founded
- 2001
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $46,641 |
| FY2023 | $87,490 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| T spot TB reagents option year 1 | Veterans Integrated Service Network 2 (VHA) | $46,641 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Quest Diagnostics TB LLC | — | 621511 Medical Laboratories |
| Euroimmun US Incorporated | Mountain Lakes, NJ | 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers |
| Foundation For Innovative New Diagnostics (Find) | Le Grand-Saconnex, GE | — |
| Zeus Scientific, LLC | — | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Navix Diagnostix, Inc. | Taunton, MA | 621512 Diagnostic Imaging Centers |
About the company
Oxford Immunotec USA, Inc., doing business as Oxford Immunotec and a subsidiary of Revvity Inc. Medical Imaging, LLC, is a leading global diagnostics company offering an FDA approved Tuberculosis test, T SPOT.TB, for detection and diagnosis of latent tuberculosis infection. The company has been registered in SAM.gov since August 2021 as a foreign-owned, for-profit corporate entity.
Oxford Immunotec USA, Inc. has primarily provided T SPOT TB reagents to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VHA VISN 2) through firm-fixed-price blanket purchase agreement call contracts. These contracts, with a total value exceeding $400,000, have supplied the diagnostic test kits for tuberculosis screening programs within the VA medical network covering the New England region. No set-aside designations were used for these awards, awarded as sole-source procurements given Oxford Immunotec's proprietary T SPOT TB test.
In October 2021, Oxford Immunotec USA, Inc. was awarded a 5-year blanket purchase agreement by VHA VISN 2 with a potential value of $1,128,588.50 to provide T SPOT TB reagents through September 2026. Three firm-fixed-price call contracts totaling over $400,000 have been issued to date against this BPA for the delivery of tuberculosis diagnostic test kits from the company's facility in Marlborough, Massachusetts. These awards enable Oxford Immunotec to continue supplying its FDA-approved T SPOT TB test as an essential component of the VHA's tuberculosis screening and prevention efforts in New England healthcare facilities.
Quick answers
Is Oxford Immunotec Usa, Inc. registered in SAM.gov?
Oxford Immunotec Usa, Inc.'s SAM.gov registration expired on March 19, 2024.
How much has Oxford Immunotec Usa, Inc. received in federal contracts?
Federal contracts obligated $134,131 to Oxford Immunotec Usa, Inc. in fiscal years 2023 through 2027.
What is Oxford Immunotec Usa, Inc.'s most recent federal award?
Oxford Immunotec Usa, Inc.'s most recent federal contract award is T spot TB reagents option year 1 (36C24223N0099), from Veterans Integrated Service Network 2 (VHA), on October 1, 2022.
On GovTribe
See Oxford Immunotec Usa, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors